C. Downie

发表

Engraftment rates related to busulphan and cyclophosphamide dosages for displacement bone marrow transplants in fifty children.

P. Shaw, J. Hobbs, K. Hugh-Jones, 1986, Bone marrow transplantation.

Monitoring of veno-occlusive disease after bone marrow transplantation by serum aminopropeptide of type III procollagen

B. Portmann, P. Cheeseman, J. Risteli, 1993, The Lancet.

Monitoring cytokine production in peripheral blood during acute graft-versus-host disease following allogeneic bone marrow transplantation.

A. Rowbottom, P. Riches, J. Hobbs, 1993, Bone marrow transplantation.

Bone marrow transplantation for Glanzmann's thrombasthenia.

A. Goodall, A. Vellodi, C. Downie, 1994, Bone marrow transplantation.

Bone marrow transplantation for thalassaemia: experience of two British centres.

A. Vellodi, S. Picton, D. Evans, 1994, Bone marrow transplantation.

Allogeneic bone marrow transplantation for fucosidosis.

E. Young, A. Vellodi, B. Winchester, 1995, Bone marrow transplantation.

Busulphan and cyclophosphamide cause little early toxicity during displacement bone marrow transplantation in fifty children.

P. Shaw, J. Hobbs, K. Hugh-Jones, 1986, Bone marrow transplantation.

Converting Adult Pancreatic Islet α Cells into β Cells by Targeting Both Dnmt1 and Arx.

S. Quake, P. MacDonald, Harini Chakravarthy, 2017, Cell metabolism.